Tirzepatide's SURMOUNT-5 head-to-head vs semaglutide (2025): Zepbound demonstrated 47% greater relative weight loss vs Wegovy in a direct Phase 3b comparison the most commercially significant clinical trial result in the obesity market, directly challenging Novo Nordisk's market leadership
Most available evidence comes from laboratory and animal studies, where researchers have observed potential effects on: Tendon healing Ligament repair Muscle recovery Gastrointestinal tissue repair Angiogenesis Inflammatory signaling Although these findings are promising, robust human clinical trials remain limited
Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats
H.AfsharH.RoohafzaH.et al
The 23-time Grand Slam champ is the new celebrity ambassador for telehealth company Ro specifically, the direct-to-patient healthcare platforms FDA-approved GLP-1 treatments, which reduce glucose levels among those with Type 2 diabetes and help support weight loss
No fillers, only pure ingredients